Following the administration of 4 mg of tritiated betamethasone, with specific activity 75 
swallowed by a normal individual. Urine, plasma and mixed saliva were subsequently collected at the times and in the volumes given in 6/3,17 ,20£: 21-tetrahydroxy-2a-methyl-pregn-4-en-3-one {Bush&Mahesh 1959¿) . Metabolites 2 and 3 were excreted as if 2/3rds. protein-bound and their concentration in the saliva was consistent with their decreasing polarity.
In the middle 'acetate' strip of Fig. 4 2/3rds of the radioactivity ran with betamethasone acetate (Metabolite 5). When standard betamethasone was acetylated by our procedure 10'°/o of the product ran in the position of metabolite 6. It is likely therefore that this artefact accounted for much of metabolite 6 in Fig. 4 .
The metabolite of major interest is No. 9 in the non-polar chromatogram. The metabolites 8 and 10 on either side of it show the expected correspondence between plasma, saliva and urine. (The peak for 10 in urine looks insignificant but it represents only a small fraction of the amount of radioactivity actually measured which showed a highly significant peak). By contrast the concen¬ tration of metabolite 9 in saliva is far too high for either the plasma con¬ centration or the rate of excretion in the urine. The most reasonable ex¬ planation of this finding is that it is a metabolite that is formed in the salivary glands. In Fig. 6 the concentration of betamethasone and of metabolite 9 in plasma and saliva and their rate of excretion in the urine are set out for each of the comparable periods. The structure of metabolite 9 has not yet been firmly established but the following observations suggest that it is 11-dehydrobetamethasone. (1) 
